Here are the past week’s top headlines on Healio.com/OSN:
Akorn loses Fresenius appeal; CEO to step down
The Delaware Supreme Court upheld a lower court decision allowing Fresenius Kabi to back out of a $4.3 billion acquisition of Akorn, prompting Akorn CEO Raj Rai to step down. Read more.
FDA approves Alembic’s allergic conjunctivitis treatment
The solution is therapeutically equivalent to Patanol ophthalmic solution 0.1% (Novartis). Read more.
AAO: Keep safety standards high in scope-of-practice expansions
The American Academy of Ophthalmology agrees with a joint
Uncategorized